AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $203.60, giving the company a market capitalization of 315.45B. It carries a P/E multiple of 30.85 and pays a dividend yield of 1.5%.
On 2026-04-06, AstraZeneca(AZN) stock traded between a low of $203.60 and a high of $203.60. Shares are currently priced at $203.60, which is 0.0% above the low and 0.0% below the high.
AstraZeneca(AZN) shares are trading with a volume of 280, against a daily average of 2.09M.
During the past year, AstraZeneca(AZN) stock moved between $122.48 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $122.48 at its lowest and $212.71 at its peak.
AZN News
Innate Pharma S.A. ((FR:IPH)) has held its Q4 earnings call. Read on for the main highlights of the call. End of Quarter Sale - 50% Off TipRanks Unlock hedge fu...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...
Analyst ratings
81%
of 31 ratingsMore AZN News
Goldman Sachs analyst Rajan Sharma assumed coverage of AstraZeneca’s (AZN) U.S. shares with a Buy rating and $220 price target The firm believes the positive Ph...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
...
Regional expansion was probably the biggest driver of growth for the treatment, Chief executive of AstraZeneca’s rare-disease unit Alexion, Marc Dunoyer said. C...
AstraZeneca (AZN) announced the efzimfotase alfa Phase III clinical programme, designed to study a broad hypophosphatasia, HPP, patient population, demonstrated...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.